ZBH.SW (Zimmer Biomet Holdings, Inc.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for ZBH.SW and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for ZBH.SW and 80,000+ other tickers.
See exactly how ZBH.SW's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ZBH.SW and 80,000+ other tickers.
Zimmer Biomet Holdings, Inc., along with its various subsidiaries, is a prominent player in the global musculoskeletal healthcare industry, providing its specialized solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. The company's comprehensive offerings span the design, manufacture, and commercialization of a wide array of innovative devices and products. These include orthopedic reconstructive solutions for knees and hips; S.E.T. offerings such as sports medicine, biologics, foot and ankle care, extremity treatments, and trauma interventions; spinal…

/PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet

/PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet